… patients with coronary heart disease. … cardiovascular events in patients with COVID-19. It
is uncertain whether NLR could be a biomarker to predicting cardiovascular events in patients …

… In summary, a total of 44 coronary heart disease patients scheduled for elective, non-cardiac
surgery was screened for eligibility. Of those, 40 patients were successfully enrolled into the …

… Inflammatory markers, such as neutrophils and lymphocytes, for risk stratification of … in
patients with cardiovascular disease may provide benefit for patient selection for cardiac surgery. …

… neutrophil-to-lymphocyte ratio (NLR) is an emerging biomarker useful for predicting the risk
and prognosis of cardiovascular diseases … for patients with cardiovascular (CV) disease [11]. …

… neutrophil-to-lymphocyte ratio and long-term cardiac … coronary artery disease. Atherosclerosis.
2017;265:35-40. … An elevated neutrophil-lymphocyte ratio independently predicts mortality …

… However, NLR has been shown to independently predict the risk of ESRD in patients
with advanced CKD, and to a small extent, in patients with early CKD [Citation11]. …

… NLR also predicts poor outcomes in patients with established … CHF patients, an elevated
NLR independently predicts atrial fibrillation and major adverse cardiovascular events (cardiac …

… The neutrophil–lymphocyte ratio (… predict cardiovascular (CV) events. The aims of this
study are to determine whether the NLR predicts incident major adverse cardiovascular events (…

… with the adverse outcomes of coronary artery disease (CAD), less is … of cardiovascular
events although neutrophils alone are associated with inflammation and cardiovascular diseases. …

… neutrophil–lymphocyte (NLR) and platelet–lymphocyte ratios (PLR) in complete blood counts
in acute myocardial infarction and other cardiovascular diseases … neutrophils, lymphocytes …